This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roy, L. F. Articles by Leenen, F. H. Search for Related Content PubMed PubMed Citation Articles by Roy, L. F. Articles by Leenen, F. H.

Circulation, Vol 79, 383-392, Copyright © 1989 by American Heart Association

ARTICLES

Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men

LF Roy, RI Ogilvie, P Larochelle, P Hamet and FH Leenen
Hypertension Unit, Toronto Western Hospital, Ontario, Canada.

To assess the contribution of venous effects to the hemodynamic changes caused by atrial natriuretic factor (ANF), the cardiac and peripheral effects of ANF were compared with those induced by the venoarterial vasodilator sodium nitroprusside. On 3 different days, eight healthy subjects received 2-hour infusions of either ANF, sodium nitroprusside, or placebo, by a single-blind crossover design. ANF was administered at a rate of 15 ng/kg/min for hour 1 and 50 ng/kg/min for hour 2; each infusion rate was preceded by a 50-micrograms bolus. The lower ANF infusion rate increased plasma cGMP fourfold, but only modest cardiovascular effects (small decreases in left ventricular end- diastolic and end-systolic volumes) were noted. At the higher ANF infusion rate, left ventricular volumes and intravascular volume, as indirectly assessed by changes in hematocrit levels, decreased further, which resulted in decreases in stroke volume, cardiac index, and systolic blood pressure. No evidence for arterial vasodilation (no decrease in diastolic blood pressure, total peripheral resistance, or forearm resistance) was obtained, and no increase in sympathetic activity was noted. In contrast, sodium nitroprusside caused arterial vasodilation, an increase in cardiac index, and significant increases in sympathetic activity. We conclude that short-term increases in plasma ANF within the physiologic range primarily affect the venous vascular bed (by decreasing intravascular volume or by venodilation) without increasing sympathetic activity.

This article has been cited by other articles:

				D. Cozzolino, F. C. Sasso, D. Cataldo, D. Gruosso, A. Giammarco, A. Cavalli, C. Di Maggio, G. Renzo, T. Salvatore, D. Giugliano, et al. Acute Pressor and Hormonal Effects of {beta}-Endorphin at High Doses in Healthy and Hypertensive Subjects: Role of Opioid Receptor Agonism J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5167 - 5174. [Abstract] [Full Text] [PDF]

				C. Sala, B. Ambrosi, and A. Morganti Blunted Vascular and Renal Effects of Exogenous Atrial Natriuretic Peptide in Patients with Cushing's Disease J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1957 - 1961. [Abstract] [Full Text]

				I. Pham, S. Sediame, G. Maistre, F. Roudot-Thoraval, P.-E. Chabrier, A. Carayon, and S. Adnot Renal and vascular effects of C-type and atrial natriuretic peptides in humans Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1457 - R1464. [Abstract] [Full Text] [PDF]

				Y. Hirata, H. Hayakawa, Y. Suzuki, E. Suzuki, H. Ikenouchi, O. Kohmoto, K. Kimura, K. Kitamura, T. Eto, K. Kangawa, et al. Mechanisms of Adrenomedullin-Induced Vasodilation in the Rat Kidney Hypertension, April 1, 1995; 25(4): 790 - 795. [Abstract] [Full Text]